Compare STTK & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STTK | TCBX |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.8M | 659.5M |
| IPO Year | 2020 | 2021 |
| Metric | STTK | TCBX |
|---|---|---|
| Price | $7.30 | $45.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $10.00 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 1.3M | 117.2K |
| Earning Date | 05-01-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.02 | 36.33 |
| EPS | N/A | ★ 1.97 |
| Revenue | ★ $1,000,000.00 | N/A |
| Revenue This Year | N/A | $29.99 |
| Revenue Next Year | N/A | $10.14 |
| P/E Ratio | ★ N/A | $23.10 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.80 | $35.73 |
| 52 Week High | $8.33 | $45.58 |
| Indicator | STTK | TCBX |
|---|---|---|
| Relative Strength Index (RSI) | 54.26 | 73.60 |
| Support Level | $5.87 | $36.41 |
| Resistance Level | $7.75 | N/A |
| Average True Range (ATR) | 0.52 | 1.07 |
| MACD | -0.03 | 0.14 |
| Stochastic Oscillator | 55.08 | 95.03 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates twenty branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, one branch in Ballinger, Texas, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.